BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16153217)

  • 1. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
    Shabsigh R; Burnett AL; Eardley I; Sharlip ID; Ellsworth PI; Garcia CS; Natanegara F; Ahuja S
    BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
    J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
    Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
    Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study.
    Wespes E; Moncada I; Schmitt H; Jungwirth A; Chan M; Varanese L
    BJU Int; 2007 Jan; 99(1):121-6. PubMed ID: 17227498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of tadalafil: an update.
    Carson CC; Rajfer J; Eardley I; Carrier S; Denne JS; Walker DJ; Shen W; Cordell WH
    BJU Int; 2004 Jun; 93(9):1276-81. PubMed ID: 15180622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
    J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation.
    Althof SE; Rubio-Aurioles E; Kingsberg S; Zeigler H; Wong DG; Burns P
    Urology; 2010 Jun; 75(6):1358-63. PubMed ID: 20206967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success.
    Shabsigh R; Donatucci C; Costabile R; Perelman MA; Burns P; Zeigler H; Wong DG
    Int J Impot Res; 2010; 22(1):1-8. PubMed ID: 19657349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
    von Keitz A; Rajfer J; Segal S; Murphy A; Denne J; Costigan T; Lockhart D; Beasley CM; Emmick JT
    Eur Urol; 2004 Apr; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY; Lee SW; Kim SW; Yang DY; Park NC; Min KS; Park K; Paick JS; Dyachkova Y; Dwight T; Lee MS
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Kim ED; Rosen RC; Shinghal R; Natanegara F; Muram D; Wong DG
    Int J Impot Res; 2008; 20(6):554-60. PubMed ID: 18997808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status.
    Shabsigh R; Broderick GA; Althof S; Natanegara F; Wong DG
    Int J Impot Res; 2009; 21(5):285-91. PubMed ID: 19536126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
    Hatzichristou D; Gambla M; Rubio-Aurioles E; Buvat J; Brock GB; Spera G; Rose L; Lording D; Liang S
    Diabet Med; 2008 Feb; 25(2):138-46. PubMed ID: 18290855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction.
    Schulman CC; Shen W; Stothard DR; Schmitt H
    Urology; 2004 Oct; 64(4):783-8. PubMed ID: 15491720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.